Alembic Pharma May 15 Board Meeting Announcement

Alembic Pharmaceuticals board meeting scheduled for May 15, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Board will consider recommending dividend for FY2026 during the meeting.
Trading window closure remains in effect until 48 hours after financial results declaration.
Disclosure made to BSE and NSE as regulatory compliance under code of conduct.